<i>Enterococcus</i> peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
2021 · Science · 324 citations
https://doi.org/10.1126/science.abc9113
G
Gary R. Fanger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
4.9K
Citations
35
h-index
49
i10-index
Gary R. Fanger is an academic researcher. The author has contributed to research in topics: Epigenetics and DNA Methylation & Melanoma and MAPK Pathways & Protein Kinase Regulation and GTPase Signaling. The author has an h-index of 35, co-authored 59 publications.
ORCID: 0000-0001-5296-0730Papers by this author
works14-3-3 Proteins Interact with Specific MEK Kinases
1998 · Journal of Biological Chemistry · 147 citations
https://doi.org/10.1074/jbc.273.6.3476
GTPase-Deficient Gα <sub>16</sub> and Gα <sub>q</sub> Induce PC12 Cell Differentiation and Persistent Activation of cJun NH <sub>2</sub> -Terminal Kinases
1996 · Molecular and Cellular Biology · 123 citations
https://doi.org/10.1128/mcb.16.2.648
Rewriting the Epigenetic Code for Tumor Resensitization: A Review
2014 · Translational Oncology · 38 citations
https://doi.org/10.1016/j.tranon.2014.08.003
The Implications of Hyponitroxia in Cancer
2014 · Translational Oncology · 27 citations
https://doi.org/10.1016/j.tranon.2014.02.001
The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent
2015 · Redox Biology · 17 citations
https://doi.org/10.1016/j.redox.2015.09.035
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat